Business · 12/05/2021

FDA Announces Final Guidance on Qualified Infectious Disease Product Designation

The FDA has released a final guidance document outlining its policies and procedures for designating qualified infectious disease products, which were created under the Food and Drug Administration Safety and Innovation Act to encourage the development of antibacterial and antifungal treatments for serious infections.